Home/Filings/4/0000899243-18-014568
4//SEC Filing

Estrem Paul 4

Accession 0000899243-18-014568

CIK 0001461993other

Filed

May 30, 8:00 PM ET

Accepted

May 31, 5:22 PM ET

Size

5.0 KB

Accession

0000899243-18-014568

Insider Transaction Report

Form 4
Period: 2018-05-29
Estrem Paul
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2018-05-29$5.00/sh+10,000$50,00010,000 total
Footnotes (1)
  • [F1]These shares were purchased from the underwriters pursuant to an underwritten public offering by the Issuer. The offering closed on May 29, 2018.

Issuer

MELINTA THERAPEUTICS, INC. /NEW/

CIK 0001461993

Entity typeother

Related Parties

1
  • filerCIK 0001722374

Filing Metadata

Form type
4
Filed
May 30, 8:00 PM ET
Accepted
May 31, 5:22 PM ET
Size
5.0 KB